Targeted suppression of AR-V7 using PIP5K1α inhibitor overcomes enzalutamide resistance in prostate cancer cells.
about
ISA-2011B, a Phosphatidylinositol 4-Phosphate 5-Kinase α Inhibitor, Impairs CD28-Dependent Costimulatory and Pro-inflammatory Signals in Human T Lymphocytes.Impact of novel miR-145-3p regulatory networks on survival in patients with castration-resistant prostate cancer.Multimodal actions of the phytochemical sulforaphane suppress both AR and AR-V7 in 22Rv1 cells: Advocating a potent pharmaceutical combination against castration-resistant prostate cancer.BMI1 regulates androgen receptor in prostate cancer independently of the polycomb repressive complex 1.
P2860
Targeted suppression of AR-V7 using PIP5K1α inhibitor overcomes enzalutamide resistance in prostate cancer cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeted suppression of AR-V7 ...... ance in prostate cancer cells.
@en
Targeted suppression of AR-V7 ...... ance in prostate cancer cells.
@nl
type
label
Targeted suppression of AR-V7 ...... ance in prostate cancer cells.
@en
Targeted suppression of AR-V7 ...... ance in prostate cancer cells.
@nl
prefLabel
Targeted suppression of AR-V7 ...... ance in prostate cancer cells.
@en
Targeted suppression of AR-V7 ...... ance in prostate cancer cells.
@nl
P2093
P2860
P50
P356
P1433
P1476
Targeted suppression of AR-V7 ...... tance in prostate cancer cells
@en
P2093
Anette Gjörloff Wingren
Brian Robinson
Heather Johnsson
Julius Semenas
Nishtman Dizeyi
Per-Anders Abrahamsson
P2860
P304
63065-63081
P356
10.18632/ONCOTARGET.11757
P407
P577
2016-09-01T00:00:00Z